![](/img/cover-not-exists.png)
The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
Rudolph M. Navari, Cindy K. Nagy, Sarah E. GrayVolume:
21
Language:
english
DOI:
10.1007/s00520-012-1710-6
Date:
June, 2013
File:
PDF, 199 KB
english, 2013